Lamotrigine for psychiatric disorders during pregnancy

Lamotrigine monotherapy is not associated with increased risk of congenital abnormalities or adverse pregnancy outcomes but data are limited—also consider Principles of psychotropic use during pregnancy.

Lamotrigine clearance can increase by up to 50% in late pregnancy—a dose increase, with a corresponding dose reduction after delivery, is often required—see here for further information.